Promising developments in new gene editing trials continue to drive investor interest in the growing biotech sector. Potential advancements include the…
Treatments utilizing Clustered Regularly Interspace Short Palindromic Repeats (CRISPR), continue to rack up clinical success. The latest research on blood…